Immupharma (IMM)

All online trades £12.50 plus an annual Management Fee of £35 & VAT with Selftrade. Apply

 58.75p
   
  • Change Today:
      0.000p
  • 52 Week High: 99.50
  • 52 Week Low: 57.00
  • Currency: UK Pounds
  • Shares Issued: 81.53m
  • Volume: 3,100
  • Market Cap: £47.90m
  • RiskGrade: 161
  • Beta: 0.09

Latest ShareCast News

ImmuPharma's losses grow in 2011

Date: Tuesday 27 Mar 2012

Drug development firm ImmuPharma increased its losses during 2011 but managed to regain the rights to its most important compound.

Immupharma ShareCast News

SABMiller exec buys a round 24-Jan-2012 ShareCast
Immupharma posts wider losses 05-Apr-2011 ShareCast
Small caps round-up: White Young Green, Beowulf,... 19-Nov-2009 ShareCast

Immupharma Regulatory News

Annual General Meeting: 2012 23-May-2012 12:20 RNS
Posting of Annual Report and AGM Notice 17-Apr-2012 07:00 RNS
Preliminary Results 27-Mar-2012 07:00 RNS
Notification of Full Year Results 20-Mar-2012 07:00 RNS
Appoints Head of Investor Relations 29-Feb-2012 07:00 RNS-R

Immupharma Newspaper Links

No recent information was found.

Immupharma Tips & Analysis

FTSE close: Morrisons down; BG Group up 20-Nov-2009 Daily Mail
Market report: Tuesday latest 20-May-2008 Daily Mail
Market report: Thursday latest 06-Dec-2007 Daily Mail
In the know 22-Dec-2006 Times
Market report: Vodafone fears prove powerful on ... 22-Dec-2006 Telegraph

Immupharma News Wires

No recent information was found.

Other Immupharma News

Mining firm could see its production leap 22-Jun-2011 This Is Money
Oil and gas minnow has big plans 16-Jun-2011 This Is Money
North African oil explorer set for soaring profits 08-Jun-2011 This Is Money
Promotional product maker set to shine 01-Jun-2011 This Is Money
Copper and gold explorer set to glisten 25-May-2011 This Is Money

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Immupharma Market Data

Currency UK Pounds
Share Price 58.75p
Change Today 0.000p
% Change 0.00 %
52 Week High 99.50
52 Week Low 57.00
Volume 3,100
Shares Issued 81.53m
Market Cap £47.90m
Beta 0.09
RiskGrade 161

Immupharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
45.28% below the market average45.28% below the market average45.28% below the market average45.28% below the market average45.28% below the market average
19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average
Price Trend
65.17% below the market average65.17% below the market average65.17% below the market average65.17% below the market average65.17% below the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average
Income Not Available
Growth
4.32% below the market average4.32% below the market average4.32% below the market average4.32% below the market average4.32% below the market average
10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average10.2% below the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 1
Sell 0
Strong Sell 1
Total 4
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Immupharma Dividends

No dividends found

Trades for 31-May-2012

Time Volume / Share Price
09:47 3,100 @ 57.64p

Immupharma Key Personnel

Chair Richard Warr
CEO Dimitri Dimitriou

Top of Page